Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Muscarinic Hypothesis of Schizophrenia: an [11C]MK-6884 PET Study Study Protocol

NCT06278246 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.

NCT NCT06278246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06278246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Muscarinic Hypothesis of Schizophrenia: an [11C]MK-6884 PET Study Study Protocol
Lead sponsor
Centre for Addiction and Mental Health
Phase
Observational
Overall status
Active, not recruiting
Start date
March 11, 2024
Completion date
March 31, 2026
Enrollment
58 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia, schizophreniform disorders